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Whereas the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (Met-Leu-Phe), induced 
NADPH-oxidase-catalyzed superoxide (0;) formation in human neutrophils, purine and pyrimidine nucleotides 
per se did not stimulate NADPH oxidase but enhanced 0; formation induced by submaximally and maximally 
stimulatory concentrations of Met-Leu-Phe up to fivefold. On the other hand, Met-Leu-Phe primed neutrophils 
to generate 0; upon exposure to nucleotides. At a concentration of 100 pM, purine nucleotides enhanced 0; 
formation in the effectiveness order adenosine 5’-0-[3-thio]triphosphate (ATP[yS]) > ITP > guanosine 5’-0-[3- 
thioltriphosphate (GTP[yS]) > ATP = adenosine 5’-0-[2-thio]triphosphate (Sp-diastereomer) = GTP = 
guanosine 5’-0[2-thio]diphosphate (GDP[PS] = ADP > adenosine 5’-[P,y-imido]triphosphate = adenosine 5’- 
0-[2-thio]triphosphate] (Rp-diastereomer). Pyrimidine nucleotides stimulated Met-Leu-Phe-induced 0; forma- 
tion in the effectiveness order uridine 5’-0-[3-thio]triphosphate (UTP[yS]) > uridine 5’-0-[2-thio]diphosphate 
(UDP[pS]) = uridine 5’-0[2-thio]triphosphate (Rp-diastereomer) (Rp)-UTP[BS]) = UTP > CTP. Uracil 
nucleotides were similarly effective potentiators of 0; formation as the corresponding adenine nucleotides. 
GDP[PS] and UDP[PS] synergistically enhanced the stimulatory effects of ATP[yS], GTP[yS] and UTP[yS]. Purine 
and pyrimidine nucleotides did not induce degranulation in neutrophils but potentiated Met-Leu-Phe-induced 
release of P-glucuronidase with similar nucleotide specificities as for 0; formation. In contrast, nucleotides per 
se induced aggregation of neutrophils. Treatment with pertussis toxin prevented aggregation induced by both 
nucleotides and Met-Leu-Phe. Our results suggest that purine and pyrimidine nucleotides act via nucleotide 
receptors, the nucleotide specificity of which is different from nucleotide receptors in other cell types. Neutrophil 
nucleotide receptors are coupled to guanine-nucleotide-binding proteins. As nucleotides are released from cells 
under physiological and pathological conditions, they may play roles as intercellular signal molecules in neutrophil 
activation 
Human neutrophils play a major role in host defense reac- 
tions against bacterial infections and in the pathogenesis of 
various diseases such as rheumatoid arthritis, glomerulo- 
ncphritis, dermatoses, myocardial infarction and asthma [l]. 
The intercellular signal molecules, PAF, LTB4 and the 
cheinotactic peptide, Met-Leu-Phe, stimulate NADPH- 
oxidase-catalyzed 0; formation [2 - 51. Combinations of 
Met-Leu-Phe plus PAF or LTB4 synergistically induce 0: 
formation [2]. In addition to 0; formation, these agents in- 
duce degranulation and aggregation [2 - 51. Receptors for 
Met-Leu-Phe, PAF and LTB4 interact with G proteins lead- 
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Abbreviations. ADP[PS], adenosine 5’-0-[2-thio]diphosphate; 
(Sp)-ATP[aS], Sp-diastereomer of adenosine 5’-0-[l-thio]triphos- 
phate; (Rp)-ATP[BS], Rp-diastereomer of adenosine 5’-0-[2-thio]tri- 
phosphate; (Sp)-ATP[pS], Sp-diastereomer of adenosine 5’-0-[2- 
thioltriphosphate; ATP[yS], adenosine 5’-0-[3-thio]triphosphate; 
[c(,P-CH2]ATP, adenosine 5’-[a,B-methylene]triphosphate; [D,y- 
CH,]ATP, adenosine 5’-[p,y-methylene]triphosphatc; [p,y-NHIATP, 
adenosine 5’-[p,y-imido]triphosphate; Met-Leu-Phe, N-formyl-L- 
methionyl-L-leucyl-L-phenylalanine; G protein, guanine-nucleotide- 
ing to the activation of phospholipase C. This lipase catalyzes 
the hydrolysis of phosphatidylinositol 4,s-bisphosphate to 
diacylglycerol and inositol trisphosphate. Diacylglycerol acti- 
vates protein kinase C, and inositol trisphosphate mobilizes 
intracellular calcium [ S ] .  ADP-ribosylation of G proteins by 
pertussis toxin prevents receptor-mediated cell activation [6, 
71. The mechanism by which Met-Leu-Phe, PAF and LTB, 
induce cellular activation has been suggested to involve both 
protein kinase C and calcium mobilization [5, 8, 91. 
We and others recently provided evidence that activation 
of NADPH oxidase involves more direct regulation by G 
binding protein; GDP[BS], guanosine 5’-0-[2-thio]diphosphate; 
GTP[yS], guanosine 5’-0-[3-thio]triphosphate; [B,y-CH,]GTP, 
guanosine 5’-[/?,y-methylene]triphosphate; [/l,y-NH]GTP, guanosine 
5’-[p,y-imido]triphosphate; LTB,, leukotriene B4; OF, superoxide 
anion; PAF, platelet-activating factor; UDP[PS], uridine 5’-0-[2- 
thioldiphosphate; (Rp)-UTP[pS], Rp-diastereomer of uridine 5’-0-[2- 
thioltriphosphate; UTP[yS], uridine 5’-0-[3-thio]triphosphate]. 
Enzymes. Adenylate kinase (EC 2.7.4.3); B-glucuronidase (EC 
3.2.1.31); lactate dehydrogenase (EC 1.1.1.27); NADPH oxidase (EC 
1.6.99.6); nucleoside-diphosphate kinase (EC 2.7.4.6); protein kinase 
C (EC 2.7.1.37); superoxide dismutase (EC 1.15.1.1.). 
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proteins [lo-141. This was suggested by the finding that the 
phosphorothioate analogue of GTP, GTPIyS], enhanced 0; 
formation in cell-free systems severalfold and that the corre- 
sponding GDP analogue, GDP[BS], competitively antag- 
onized the effects of GTP[yS] [lo, 141. Similar observations 
with CTP[yS] and GDP[PS] have been made for several G- 
protein-regulated effector systems including the regulation of 
phospholipase C in permeabilized cells [15- 171. 
Under physiological and even more so under pathological 
conditions such as inflammation, thrombosis, hemorrhage, 
hypoxia and trauma, nucleotides are released into the extra- 
cellular space from a variety of cellular systems including 
neurones, chromaffin cells, endothelium, platelets, and dam- 
aged tissues [18 -221. Released ATP binds to purinoceptors 
which regulate many cell functions [19,23]. Purinoceptors can 
be divided into subtypes according to the effectiveness order 
of purinergic agonists [19, 231. Phosphorothioate analogues 
of adenine nucleotides are useful tools to study the stereo- 
specificity of purinoceptors [24, 251. In addition to their direct 
effects on G proteins [lo, 14- 171, both GTP[yS] and GDP[PS] 
prevent activation of intact platelets via competitive antagon- 
ism with ADP at purinoceptors [26, 271. 
In addition to ATP, UTP modulates cellular functions. 
UTP induces contraction or endotheliuin-dependent relax- 
ation of blood vessels, prostacyclin formation, calcium 
mobilization and metabolic changes in various cell types [18, 
21, 22, 28 - 301. The existence of pyrimidinoceptors as a class 
of nucleotide receptors was suggested by the finding that UTP 
was similarly effective as ATP in inducing cellular activation 
[18, 28, 291. 
Extracellular nucleotides play a role in the regulation of 
myeloid cells, as ATP and its phosphorothioate analogue, 
ATP[yS], induce calcium mobilization in HL-60 leukemic and 
U-937 myelo-monocytic cells and in mouse macrophages [31, 
321. In addition, nucleotides induce neutrophil aggregation 
[33, 341 and ATP stimulates the release of P-glucuronidase in 
guinea-pig neutrophils [35]. Furthermore, Kuhns et al. report- 
ed that ATP and UTP induced an increase in the intracellular 
calcium concentration and enhanced Met-Leu-Phe-induced 
0; formation in human neutrophils [36]. 
All these findings prompted us to study in detail regulation 
of neutrophil functions by extracellular nucleotides, particu- 
larly by pyrimidine nucleotides. We report that purine and 
pyrimidine nucleotides potentiate fMet-Leu-Phe-induced 0; 
formation and degranulation and per se induce aggregation 
in human neutrophils with similar effectiveness. Using various 
naturally occurring nucleotides and chemically modified de- 
rivatives, especially phosphorothioate analogues, we show 
that these activations are stereospecific and presumably in- 
volve nucleotide receptors and pertussis-toxin-sensitive G 
proteins. 
MATERIALS AND METHODS 
Synthesis of (Sp)-ATP(PS], (Rp)-ATP(PS], 
(Rp)-UTP(PS], UTP(yS] and UDP[PS] 
UDP[PS] was synthesized in analogy to the method 
published for the synthesis of ADP[BS] [37]. UTP[yS] was 
prepared by incubation of GTP[yS] and UDP in the presence 
of nucleoside-diphosphate kinase from beef liver (Boehringer 
Mannheim, Mannheim, FRG) under the conditions described 
by Goody et al. [38]. UTP[.jS] and UDP[PS] were purified by 
reverse-phase HPLC using a linear gradient of 0-15% (by 
vol.) acetonitrile in 100 mM triethylammonium bicarbonate, 
pH 7.0, within 20 min. The diastereomers of ATP[PS] were 
prepared as described [39]. The Rp-diastereomer of UTP[PS] 
was synthesized accordingly. Purity of all compounds was 
checked by ‘P-NMR-spectroscopy, showing the expected 
chemical shift values. 
Other materials 
Inorganic pyrophosphate, A23187, p-nitrophenyl p-D- 
glucuronide, [a,P-CH2]ATP, uridylyl (3’,5’)uridine and TTP 
were obtained from Sigma Chemie (Deisenhofen, FRG). All 
other nucleotides were of the highest degree of purity available 
and were obtained from Boehringer Mannheim (Mannheim, 
FRG). Stock solutions of nucleotides (10 mM) were prepared 
in 138 mM NaC1, aliquoted and stored at -20°C. LTB4 was 
a gift of Hoechst AG (Frankfurt/Main, FRG), and pertussis 
toxin was kindly provided by Dr. Motuyuki Yajima (Kyoto, 
Japan). PAF was a gift of Dr. Santosh Nigam (Abteilung fur 
Gynakologische Endokrinologie, Unversitatsklinikum Steg- 
litz, Freie Universitat Berlin). Sources of other materials have 
been described elsewhere [lo- 13, 401. 
Preparation of human neutrophils 
Heparinized blood was obtained by venous puncture from 
healthy volunteers of either sex who had taken no drugs for 
at least three weeks. Neutrophils were isolated by dextran 
sedimentation and centrifugation through Ficoll-Hypaque 
[lo, 11,40,41]. Cell preparations consisted of more than 98% 
viable neutrophils as judged by trypan blue dye exclusion. 
Assay for  0;-generation 
NADPH-oxidase-catalyzed 0; generation was monitored 
by continuous measurement of ferricytochrome c reduction 
inhibitable by superoxide dismutase, using an Uvikon 810 
dual-beam spectrophotometer (Kontron, Eching, FRG). Re- 
action mixtures (500 p1) contained 1-2 x lo6 neutrophils, 
100 pM ferricytochrome c and a buffer consisting of 138 mM 
NaCl, 6 m M  KCl, 1 mM MgC12. 1 mM CaC12, 1 mM 
Na2HP04, 5 mM NaHC03, 5.5mM glucose and 20mM 
Hepes, pH 7.4. Reaction mixtures were preincubated for 
3 min at 37°C. 0; generation was initiated by the addition 
of stimuli [40]. All assays were performed in the absence of 
cytochalasin B. The formation of 0; was completed within 
1 - 12 min, depending on the stimuli used. The total amounts 
of 0; generated were calculated according to Markert et al. 
[41], and these values are shown in the tables and figures. 
Assay.for release of P-glucuronidase 
Neutrophils (2.5 - 5 x lo6 cells) were suspended in 500 pl 
of the buffer described above and were incubated for 5 min 
at 37°C in the presence of cytochalasin B ( 5  pg/ml). Reactions 
were initiated by the addition of stimuli. After 10 min, reac- 
tions were terminated by placing the tubes onto melting ice. 
Reaction mixtures were centrifuged for 10 min at 250 x g. The 
determinations of P-glucuronidase and lactate dehydrogenase 
activities of the supernatant fluids of reaction mixtures and 
of cell lysates were performed as described [42]. 
Aggregation of neutrophils 
Aggregation was measured by turbidometry [4,8]. Neutro- 
phils (5 x lo6) were suspended in 900 p1 of the buffer described 
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Fig. 1. Kinetics of 0: formation in neutrophils. (A) Addition of either 
100 pM UTP[.?S] (trace l ) ,  30 nM Met-Leu-Phe (trace 2) or 100 pM 
UTP[yS] plus 30 nM met-Leu-Phe (trace 5) ;  (B) addition of 100 pM 
UTP[yS] (trace 3) or solvent (trace 2, dotted line) to assays containing 
30 nM fMet-Leu-Phe; (C) addition of 30 nM met-Leu-Phe (trace 4) 
or solvent (trace 1, dottcd line) to assays containing 100 pM UTP[yS]. 
Superimposed original registrations from one single experiment are 
shown. Similar results werc obtained in four experiments with 
neutrophils of different donors 
above. Cells were incubated for 3 min at 37°C in the presence 
of cytochalasin B (1 pg/ml) prior to addition of stimuli. Aggre- 
gation experiments were carried out under constant stirring 
of cells at lo3 rpm, using an Uvikon 810-dual beam spectro- 
photometer. 
RESULTS 
The effects of purine and pyrimidine nucleotides on 0; 
formation were studied. The kinetics of 0; formation are 
shown in Fig. 1. The phosphorothioate analogue of UTP, 
UTP[yS], per se did not activate 0; formation, even in the 
presence of cytochalasin B. However, at a concentration of 
100 pM, UTP[yS] enhanced 0; formation induced by Met -  
Leu-Phe (30 nM) fivefold with respect to V,,, and the total 
amount of 0; generated. The effect of UTP[yS] was rapid in 
onset, as preincubation with UTP[yS] for 6 inin prior to ad- 
dition of met-Leu-Phe did not result in a greater enhance- 
ment of 0; generation than by simultaneous addition of 
stimuli. fMet-Leu-Phe made the cells responsive to UTP[yS]. 
After cessation of the fMet-Leu-Phe-induced 0; formation, 
UTP[yS] reactivated 0; formation to an extent amounting to 
60% of that induced by fMet-Leu-Phe. The duration of the 
UTP[yS]-induced 0; formation was shorter than that induced 
by the chemotactic peptide. Similar results as with UTP[yS] 
were obtained with UTP, ATP and UTP[yS] (data not shown). 
After cessation of the 0; formation induced by UTP[yS] or 
ATP[yS] at a concentration of 30 pM, the re-exposure to a 
tenfold higher concentration of either UTP[yS] or ATP[yS] 
did not reactivate NADPH oxidase (data not shown). These 
results indicate that activations of NADPH oxidase by 
UTP[yS] and ATP[yS] were cross-desensitized as has been 
shown for several stimuli in neutrophils [43]. 
The concentration/response curves to stimulation of fMet- 
Leu-Phe-induced 0; formation by extracellular nucleotides 
are shown in pars pro toto for ATP, ATP[yS], UTP and 
UTP[yS] (Fig. 2). Nucleotides concentration-dependently en- 
hanced Net-Leu-Phe-induced 0, formation. The effects of 
nucleotides were evident at concentrations above 0.3 1M and 
did not reach a plateau at a concentration of 100 pM. This 
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Fig. 2. Concentrationlresponse curves fo r  ATP, ATP[yS], UTP and 
UTP[yS] on fMet-Leu-Phe-induced 0; formation. Assays contained 
Met-Leu-Phe (30 nM) and various concentrations of nucleotides. 
Nucleotides and met-Leu-Phe were simultaneously added to reaction 
mixtures. (0) ATP; (0 )  ATP[yS]; (n) UTP; (m) UTPbS]. Data 
shown respresent the mean 5 SEM of eight experiments performed 
with neutrophils of different donors 
type of concentration/response curve has been observed for 
the activation of numerous cellular functions by purine and 
pyrimidine nucleotides [18, 24, 25, 441. As nucleotide concen- 
trations > 100 pM are unlikely to occur in the extracellular 
space in vivo [18, 19, 22, 291, and as nucleotides at higher 
concentrations may permeabilize cells [45, 461, the effects of 
higher concentrations of nucleotides were not investigated. In 
neutrophils nucleotides at concentrations of up to 100 pM did 
not cause cell damage as revealed by trypan blue dye exclusion 
(data not shown) and the release of lactate dehydrogenase 
(see below). 
The nucleotides specificities for NADPH oxidase acti- 
vation by purine and pyrimidine nucleotides were investi- 
gated. At a concentration of 100 pM, the purine nucleotides, 
(Rp)-ATP[PS] and [P,y-NHIATP significantly enhanced 
chemotactic-peptide-induced 0, formation in the effective- 
ness order given in Table 1. ADP[PS], (Sp)-ATP[aS], [a$- 
CHz]GTP and GDP were inactive. In contrast, adenosine 
inhibited 0; formation by more than 50%, presumably via 
adenosine A2 receptors [47]. The pyrimidine nucleotides, 
UTP[yS], (Rp)-UTP[BS], UDP[PS], UTP and CTP signifi- 
cantly enhanced met-Leu-Phe-induced 0; formation as 
shown in Table 1. In contrast, uridylyl (3',5')uridine, UDP, 
UDP-glucose, UMP, uridine, TTP, inorganic orthophosphate 
and pyrophosphate as well as the coenzymes, NAD' and 
NADP+, were inactive. UTP[yS], (Rp)-UTP[PS], UTP and 
UDP[BS] but not UDP were significantly more effective 
potentiators of 0; formation than the corresponding adenine 
nucleotides. 
As far as regulation of G proteins by phosphorothioate 
analogues is concerned, a tenfold excess of GDP[PS] 
antagonizes the stimulatory effects of GTP[yS] [lo, 14, 151. 
Therefore, we investigated the possibility that phos- 
phorothioate analogues of nucleoside diphosphates are par- 
tial antagonists at neutrophil nucleotide receptors, i. e. that 
they prevent potentiation of 0; formation by phos- 
phorothioate analogues of nucleoside triphosphates. In 
platelets, both GDP[PS] and GTP[yS] are antagonists at 
ATP[yS], ITP, GTP[yS], ATP, (Sp)-ATP[PS], GTP, ADP, 
CHzIATP, [P,y-CHzIATP, AMP, [P,y-NH]GTP, [P,Y- 
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Table 1. Nucleotide specificity for  stimulation of fMet-Leu-Phe-in- 
duced 0; formation 
Nucleotides (100 pM each) or solvent (control) were added to reaction 
mixtures simultaneously with fMet-Leu-Phe (30 nM). Data shown 
represent the mean f SEM of eight experiments performed with 
neutrophils of different donors. The numbers indicate the effective- 
ness order of nucleotides. Statistical significance of the effectiveness 
of nucleotides was assessed using the Wilcoxon test. Values of P are 
for comparison of nucleotides versus control (n.s. = not significant); 
values in brackets are comparison of UTP versus ATP, UTP[yS] versus 
ATP[yS], UDP versus ADP, UDP[,!B] versus ADP[PS] and (Rp)- 
UTP[PS] versus (Rp)-ATP[PS] 
Nucleotide 0; P 
generation 
nmol/1O6 
cells 
Control 1.5 f 0.5 
Purines 
Pyrimidine 
and other 
1. ATP[yS] 
2. ITP 
3. GTP[yS] 
4. ATP 
5. GTP 
7. GDP[fiS] 
8. ADP 
6. (Sp)-ATP@S] 
9. [P,y-NH]ATP 
10. (Rp)-ATP[PS] 
ADP[PSl 
AMP 
[P,y-CH,IATP 
GDP 
[P,y-CHzIGTP 
[P,y-N HIGTP 
Adenosine 
[GI,P-CHZ]ATP 
[SP]-ATP[CXS] 
1. UTP[yS] 
2. UDP[PS] 
3. UTP 
5. CTP 
UDP 
UDP-glucose 
NADP+ 
Pyrophosphate 
UMP 
NAD+ 
Orthophosphate 
TTP 
Uridine 
Uridyl yl-uridine 
4. (Rp)-UTP[PS] 
6.5 f 1 .O 
6.0 f 1.0 
4.6 f 1.5 
3.9 f 0.7 
3.5 f 0.7 
3.3 f 0.4 
3.2 f 1.2 
3.1 f 0.6 
2.4 f 0.8 
2.2 rt 0.3 
1.9 f 0.3 
1.6 f 0.4 
1 .4 f0 .6  
1.3f0.3 
1.3 f 0.4 
1.2 f 0.6 
1.2 f 0.6 
1.2 f 0.5 
0.5 f 0.1 
7.5 f 1.3 
5.2 f 2.1 
5.1 + 0.4 
4.8 f 0.5 
3.5 f 0.5 
2.2 f 0.8 
1.5 0.6 
1.6 f 0.5 
1.5 0.6 
1.5 f 0.5 
1.4 f 0.4 
1.4 * 0.2 
1.3 f 0.2 
1.2 f 0.3 
1.2 f 0.2 
<0.01 
< 0.01 
<0.01 
< 0.01 
<0.01 
<0.01 
<0.01 
< 0.01 
< 0.05 
< 0.05 
n.s. 
n. s. 
n. s. 
n.s. 
n.s. 
n. s. 
n. s. 
n.s. 
< 0.01 
<0.01 (<0.05) 
<0.01 ( t0 .05 )  
<0.01 
n. s. ( t0 .05 )  
n.s. 
n. s. 
n. s. 
n. s. 
n.s. 
n. s. 
n. s. 
n. s. 
n.s. 
<0.01 (<0.01) 
<0.01 (<0.01) 
purinoceptors [26,27]. ADP[PS] at a concentration of 100 pM 
neither inhibited nor significantly enhanced activation of 
NADPH oxidase by fMet-Leu-Phe plus ATP[yS], GTP[yS] or 
UTP[yS] at a concentration of 10 pM (Table 2). In contrast 
to ADP[PS], GDP[PS] and UDP[PS] per se did not only 
potentiate Met-Leu-Phe-induced 0; formation but also 
additively or synergistically enhanced NADPH oxidase acti- 
vation by fMet-Leu-Phe plus ATP[yS], GTP[yS] or UTP[yS]. 
These results demonstrate that the effects of GDP[PS] and 
GTP[yS] on NADPH oxidase in intact cells differ from those 
in cell-free systems [lo, 141. 
The effects of UTP and UTP[yS] on NADPH oxidase 
activation by various concentrations of fMet-Leu-Phe were 
studied (Fig. 3). UTP and UTP[yS] did not prime the cells to 
respond to non-stimulatory concentrations of fMet-Leu-Phe 
(1 - 3 nM), indicating that a small but over-threshold acti- 
vation of NADPH oxidase by fMet-Leu-Phe (10-30 nM) 
was required for synergistic interaction with UTP or UTP[yS]. 
The relative stimulatory effects of UTP and UTP[yS] were 
greater in the presence of submaximally stimulatory con- 
centrations of fMet-Leu-Phe than in the presence of maxi- 
mally stimulatory concentrations. Conversely, the absolute 
stimulatory effects of UTP and UTP[yS] were greater at high 
concentrations of Met-Leu-Phe. In the experiment shown in 
Fig. 3, nucleotides lowered the ECS0 for activation of 
NADPH oxidase by Met-Leu-Phe from 130 nM to 60- 
75 nM. In two separate experiments with neutrophils of differ- 
ent donors UTP reduced the EC50 for NADPH oxidase acti- 
vation by fMet-Leu-Phe from 60nM to 40nM and from 
50 nM to 30 nM (data not shown). A similar range of in- 
terindividual variation of the EC50 for NADPH oxidase acti- 
vation by fMet-Leu-Phe has been reported by Simpkins et al. 
[48]. In analogy to UTP and UTP[yS], ATP and ATP[yS] also 
lowered the ECS0 for fMet-Leu-Phe (data not shown). 
In addition to fMet-Leu-Phe, PAF and LTB4 are well- 
known activators of neutrophils [l - 3, 51. Therefore, we stud- 
ied the interactions of various stimuli on 0; formation (Tab- 
le 3). In preliminary experiments, the concentration of PAF 
and LTB4 used in the present study (300 nM for each) was 
found to be maximally effective to activate 0; formation. In 
agreement with previous results, we found that PAF and LTB4 
at maximally stimulatory concentrations activated 0; forma- 
tion much less effectively than fMet-Leu-Phe, even when the 
latter agonist was present only at a submaximally stimulatory 
concentration (30 nM) [2, 31. In addition, the activations of 
NADPH oxidase by PAF and LTB4 were very brief and lasted 
less than 3 min. These differences in the capacities of the 
intercellular signal molecules to activate NADPH oxidase 
may be explained by the fact that in contrast to Met-Leu- 
Phe, PAF and LTB4 lead only to a transient generation of 
polyphosphoinositol-lipid-derived second messengers, the 
concentrations of which may be insufficient for a prolonged 
activation of NADPH oxidase [49 - 511. fMet-Leu-Phe plus 
PAF synergistically activated NADPH oxidase to a similar 
extent as did fMet-Leu-Phe plus UTP[yS]. The combination 
of fMet-Leu-Phe plus LTB4 resulted in a less pronounced 
synergistic activation of NADPH oxidase [2]. Interestingly, 
the combination of PAF plus LTB4 was as effective in in- 
ducing 0; formation as was fMet-Leu-Phe plus LTB4. In 
contrast, UTP[yS] caused only a small but significant enhance- 
ment of PAF- or LTB,-induced 0; formation. Essentially the 
same results were obtained with ATP[yS] (data not shown). 
The effects of nucleotides on degranulation in human 
neutrophils were studied. Similarly to activation of NADPH 
oxidase, UTP[yS] and ATP[yS] (data only shown for ATP[yS]) 
per se did not induce the release of P-glucuronidase (Fig. 4). 
At a maximally stimulatory concentration (1 pM), fMet-Leu- 
Phe induced the release of 40 & 5% (mean SEM, n = 11) 
of cellular P-glucuronidase. The release of P-glucuronidase 
from neutrophils in the presence of cytochalasin B ( 5  pg/ml) 
and in the absence of agonists amounted to 6% of cellular 
content and paralleled the release of lactate dehydrogenase. In 
the presence of met-Leu-Phe at a submaximally stimulatory 
concentration (10 nM), the release of P-glucuronidase 
amounted to 12% of the cellular content. The effect of Met -  
Leu-Phe was enhanced by ATP[yS] and UTP[yS] at concen- 
trations above 1 FM without an increase in the release of 
lactate dehydrogenase. This specificity of nucleotides for the 
28 1 
Table 2. Interaction of phosphorothioate analogues of nucleoside diphosphutes ( N D P [ a S ] )  and nucleoside triphosphutes ( N T P [ y S ] )  on fMe t -  . .  . 
Leu-Phe-induced 0; generation 
Nucleotides or solvenl (control) were added to reaction mixtures simultaneously with Met-Leu-Phe (30 nM). Data shown represent the mean 
f SEM of eight experiments performed with neutrophils of different donors. The effect of phosphorothioate analogues of' nucleoside 
diphosphates on 0 2  formation in the absence or presence of phosphorothioate analogues of nucleoside triphosphates was assessed statistically 
using the Wilcoxon test; n.s. = not significant 
NTPWI (10 PM) 0 2  generation with 100 pM NDP[BS] ( P )  
none A W P S I  GWBSI  UDP[BSl 
nmoI/I06 cells 
none 1.5 f 0.5 1.9 0.3 (n.s.) 3.2 f 1.2 (< 0.05) 5.2 f 2.1 (<0.01) 
4.4 f 1.7 (n. s.) 9.4 f 2.5 (<0.01) 
5.3 f 1.7 (n.s.) 10.7 & 2.7 (<0.01) 
4.3 f 1.5 
4.0 f 1 .O 
7.0 f 1.4 ((0.05) 
8.5 f 1.6 ((0.01) 
CTP[.jS] 3.0 f 1.2 4.3 f 1.4 (n. s.) 4.7 f 0.6 (< 0.05) 7.4 f 0.2 ( < O . O l )  
ATP[YSI 
UTP[YSl 
00 9 8 7 6 
fMet-Leu-Phe (-log MI 
Fig. 3. Concentrationlresponse curve ,for fMet-Leu-Pke-induced 0, 
formation in the absence andpresence of UTP or lJTP[yS].  The effect 
of Met-Leu-Phe at various concentrations was studied in the absence 
ofnuclcotides(A)andin thepresenceof100 p M U T P ( 0 ) o r  100 pM 
UTP[yS] (m). Nuclcotides and Met-Leu-Phe were simultaneously 
added to reaction mixtures. Data shown represent the means of assay 
duplicates which varied less than 5%. Similar results were obtained 
in three experiments with neutrophils of different donors 
release of /&?I ucuronidase demonstrates that nucleotides did 
not increasc (he plasma membrane permeability. As was the 
case for potentiation of Met-Leu-Phe-induced 0; formation, 
the concentration/response curves to nucleotides for 
degranulation did not reach saturation at 100 pM. 
The nucleotide specificities for degranulation were similar 
to those for 0; formation, but the differences in the effective- 
ness of nucleotides were less marked (Table 4). At a concen- 
tration of 100 pM, ATP, ATP[yS], ITP, UTP, UTP[yS] and 
UDP[PS] were similarly effective potentiators of degranula- 
tion, whereas CTP, UDP, ADP, GTP, GTP[yS] and GDP[PS] 
were slightly less effective. In contrast, AMP, ADP[PS], (Sp)- 
[P,y-NHIGTP, [p,y-CH2]GTP, UMP and TTP did not signifi- 
cantly enhance the release of P-glucuronidase (data not 
shown). In analogy to activation of NADPH oxidase, the 
relative extent of synergistic degranulation by Wet-Leu-Phe 
and nucleotides was more pronounced at submaximally 
stimulatory concentrations of the chemotactic peptide. How- 
ever, even in the presence of a maximally stimulatory concen- 
ATP[ctS], [j,y-NH]ATP, [ct,P-CH2]ATP, [P,y-CH2]ATP, GDP, 
Table 3. Synergistic activation of 0; ,formation by combinations qf 
fMet-Leu-Phe, PAF, LTB4 and UTP(.jS] 
The concentrations of stimuli in reaction mixtures were as follows. 
Met-Leu-Phe, 30 nM; PAF and LTB4, 300 nM; UTP[yS], 100 pM. 
In the combination experiments, stimuli were added simultaneously 
to reaction mixtures. Data shown represent the mean f SEM of eight 
experiments performed with neutrophils of different donors. Thc 
statistical significance of the effects of combinations of stimuli versus 
the controls (one stimulus only) was assessed using the Wilcoxon test; 
n.s. = not significant 
Stimulus 
~ 
0, generation 
Met-Leu-Phe 
PAF 
LTB4 
Met-Leu-Phe plus PAF 
Met-Leu-Phe plus LTB4 
Met-Leu-Phe plus UTP[yS] 
PAF plus UTP[yS] 
UTP[YSl 
PAF P I U S  LTBd 
LTB4 PIUS UTP[yS] 
nmoI/106 cells 
1 .5f0 .5  
0.2 f 0.1 
0.2 f 0.1 
0 
7.6 k 2.5 ( t0 .01)  
2.3 f 0.5 (<0.05) 
7.5 f 1.5 (<0.01) 
2.1 f 1.0 (<0.01) 
0.5 k 0.1 ((0.01) 
0.4 k 0.2 (< 0.05) 
tration of Met-Leu-Phe (1 pM), ATP[yS] (100 pM) stimu- 
lated the extent of /3-glucuronidase release from 40% up to 
50% of the cellular content (data not shown). 
Finally, we investigated the effects of nucleotides on aggre- 
gation of human neutrophils. Typical superimposed aggre- 
gation traces are shown (Fig. 5) .  UTP per se induced aggre- 
gation, reaching a maximum at a concentration of 100 pM. 
Both V,,, and the maximum extent of aggregation depended 
on the nucleotide Concentration. The extent of aggregation 
induced by UTP (100 pM) amounted to 48% of that induced 
by a maximally stimulatory concentration of Wet-Leu-Phe 
(1 pM). Aggregation induced by UTP followed similar kin- 
etics as that induced by the chemotactic peptide and was 
irreversible. In addition, UTP synergistically enhanced aggre- 
gation induced by a submaximally stimulatory concentration 
of Met-Leu-Phe. At a concentration of 10 mM, fMet-Leu- 
Phe induced aggregation to an extent amounting to 34% 
of that of Met-Leu-Phe at a concentration of 1 pM. UTP 
concentration-dependently enhanced aggregation induced by 
fMet-Leu-Phe (10 nM) up to the same extent as Met-Leu- 
Phe at a maximally stimulatory concentration. The nucleotide 
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Fig. 4. Concentrationlresponse curves for ATP[yS] and UTP[yS] on 
fMet-Leu-Phe-induced release of P-glucuronidase. The release of b- 
glucuronidase from neutrophils under various conditions during an 
incubation time of 10min was determined. (0 )  Release of P- 
glucuronidase by Met-Leu-Phe (10 nM) plus ATP[yS]; (V) release 
of lactate dehydrogenase (LDH) by Met-Leu-Phe (10 nM) plus 
ATP[yS]; (m) release of b-glucuronidase by Met-Leu-Phe (10 nM) 
plus UTP[yS]; (0) release of P-glucuronidase by ATP[yS]. Data shown 
represent the mean f SEM of seven experiments performed with 
neutrophils of different donors 
specificities for the induction of aggregation are summarized 
in Table 5. ATP, ATP[yS], ITP, UTP and UTP[yS] at a concen- 
tration of 100 pM were similarly effective. ADP and CTP 
were less effective than ATP and UTP. GTP, GTP[yS], 
ADP[pS], TTP, UDP[pS] and UDP only marginally induced 
aggregation, and UMP as well as AMP were totally inactive. 
The role of pertussis toxin-sensitive G proteins in the 
activation of neutrophils by extracellular nucleotides was 
studied. In agreement with previous results [6] we found that 
treatment of neutrophils with pertussis toxin at a concen- 
tration of 1 pg/ml for 3 h completely prevented Met-Leu- 
Phe-induced 0; formation. In addition, pertussis-toxin- 
treated cells did not generate 0; upon exposure to met-Leu- 
Phe plus ATP[yS] or UTP[yS] (data not shown). Using these 
conditions of treatment pertussis toxin almost completely in- 
hibited aggregation by Net-Leu-Phe, ATP and UTP but not 
aggregation induced by the calcium ionophore, A231 87, 
which circumvents receptor-stimulation by directly increasing 
the intracellular calcium concentration (Fig. 6). These results 
indicate that both the effects of met-Leu-Phe and of extra- 
cellular nucleotides are mediated via G proteins. 
DISCUSSION 
In addition to purine nucleotides, extracellular pyrimidine 
nucleotides are known to activate various cellular functions 
with similar effectiveness as purine nucleotides [18, 22, 28 - 
30, 331. Whereas much work has been performed to elucidate 
the mechanism by which purine nucleotides mediate their 
effects, much less attention has been paid to the effects of 
pyrimidine nucleotides. As ATP and UTP are known to induce 
aggregation and calcium mobilization in white blood cells 
[31-341, we investigated human neutrophils as a model sys- 
tem for purinergic and pyrimidinergic cell activation. Due to 
the low potency of nucleotides and the presence of ecto- 
nucleotidase activity in the plasma membrane of neutrophils 
Table 4. Nucleotide specificity for  stimulation of fMet-Leu- Phe-induced 
P-glucuronidase release 
The release of /I-glucuronidase induced by Met-Leu-Phe at a concen- 
tration of 10 nM during an incubation time of 10 min was measured, 
as a percentage of cellular content, in the absence (control) and 
presence of various nucleotides at a concentration of 100 pM. The 
numbers indicate the effectiveness order of nucleotidcs. Data shown 
represent the mean f SEM of seven experimcnts performed with 
neutrophils of different donors. The effectiveness of stimuli was 
assessed statistically using the Wilcoxon test. Values of P are for 
comparison of nucleotides versus control; n.s. = no significant; 
values in brackets are comparison of UTP versus ATP, UTP[.jS] versus 
ATP[yS], UDP versus ADP and UDP[PS] versus ADP[BS] 
N ucleotide b-Glucuronidase 
re 1 ease 
P 
Control 
Purines 1. ATP 
2. ATP[yS] 
3. ITP 
4. GTP 
5 .  ADP 
6. GTP[yS] 
7. GDP[PS] 
Pyrimidines 1. UTP[yS] 
2. UTP 
3. UDP[PS] 
4. UDP 
5. CTP 
ADPtPSl 
Yo 
1 3 + 2  
30 f 7 
27 f 6 
24 f 3 
21 + 4  
20 f 6 
1 9 f 4  
1 8 f 3  
1 6 f 3  
24 + 2 
23 f 3 
23 & 6 
1 9 f 2  
1 9 + 3  
<0.01 
<0.01 
<0.01 
<0.01 
~ 0 . 0 5  
< 0.05 
< 0.05 
n.s. 
<0.01 (n.s.) 
<0.01 (n.s.) 
<0.05 (<0.05) 
<0.05 (n.s.) 
<0.05 (n.s.) 
[52], binding studies with nucleotides are difficult to perform. 
Therefore, nucleotide receptors in neutrophils at present can 
only be assessed by measuring cell functions, as is the case 
for most other nucleotide-regulated cell systems 119, 231. We 
measured 0, formation, release of B-glucuronidase and ag- 
gregation as parameters of neutrophil activation. We found 
that extracellular nucleotides activated neutrophils at concen- 
trations between 0.1 - 100 pM. As the concentration of ATP 
has been shown to reach 20 pM in the systemic circulation 
after tissue injury [19], neutrophil activation by extracellular 
nucleotides obviously is of physiological relevance. The fact 
that nucleotides per se lead only to aggregation but not to 
activation of 0, formation and degranulation suggests that 
stimulations of these functions require different signal trans- 
duction pathways. In addition, activations of 0; formation 
and degranulation appear not to be prerequisites for induction 
of aggregation. 
Several findings suggest that purine and pyrimidine nu- 
cleotides act via plasma membrane receptors. Most impor- 
tantly, nucleotide-induced aggregation of neutrophils in 
pertussis-toxin-sensitive (see Fig. 6), suggesting that nucleo- 
tide receptors interact with G proteins. Interaction of purin- 
oceptors with pertussis-toxin-sensitive G proteins has also 
been shown for inhibition of adenylyl cyclase in liver [53]. In 
addition, the desensitization of cell responses to nucleotides 
is a typical characteristic of receptor-mediated processes [43]. 
Furthermore, the stereospecificity of neutrophil activation by 
purine and pyrimidine nucleotides points to the recognition 
of nucleotides by specific receptors. 
ATP, GTP and ITP are similarly effective agonists at 
neutrophil purinoceptors. In addition, neutrophil purin- 
oceptors stereoselectively discriminate between phosphoro- 
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Table 5. Nucleotide specificity f o r  induction of neutrophil aggregation 
To stirred suspensions of neutrophils, nucleotides were added at a 
concentration of 100 pM. The extent of aggregation (measured as 
percentage light transmission) is referred to that induced by M e t -  
Leu-Phe (1 pM), which effect amounted to 100%. The numbers indi- 
cate the effectiveness order of nucleotides. Data shown represent the 
mean I SEM of 3-7 experiments performed with neutrophils of 
different donors. The effectiveness of UTP versus ATP, UTP[yS] 
versus ATP[yS], UDP versus ADP and UDP[PS] versus ADP[PS] was 
assessed statistically using the Wilcoxon test; n.s. = not significant 
Nucleotides Aggregation P 
% 
Purines 1. ATP 41 + 12 
2. ATP[yS] 36)  3 
3. ITP 29+11 
4. ADP 19+  5 
6. GTP 6 +  2 
5. ADP[PS] 9, 5 
7. GTP[yS] 5 +  4 
AMP 0 
Pyrimidines 1. UTP 48 & 12 (n. s.) 
2. UTP[yS] 3 5 + l l  (n. s.) 
3. CTP 1 9 +  5 
4. UDP[PS] 5 +  4 (n. s.) 
5.  UDP 3, 2 ( t O . O 1 )  
6. TTP 3, 1 
UMP 0 
thioate analogues of ATP and ADP (see Table I) .  In contrast, 
purinoceptors in smooth muscle cells do not show 
stereoselectivity for the diastereomers of ATP[pS], and both 
(Sp)-ATP[aS] and ADP[PS] are effective agonists at these re- 
ceptors [24, 251. In platelets, ADP is the most potent agonist, 
and in mast cells only ATP acts as an agonist at purinoceptors 
[19,54]. In addition, GDP[pS], GTP[yS] and ATP are competi- 
tive antagonists at platelet purinoceptors but agonists at 
neutrophil purinoceptors [26, 271. Furthermore, [a$-CH,]- 
ATP and [P,y-CH2]ATP are Pzx-purinoceptor agonists but 
not activators of human neutrophils [19, 231. Finally, ATP[yS] 
is a less effective agonist at P,,-purinoceptors than ATP but 
not at neutrophil purinoceptors [44]. These data suggest that 
neutrophil purinoceptors are different from purinoceptors in 
other cell types. ATP, GTP, ITP and ADP may represent the 
endogenous ligands for neutrophil purinoceptors. 
As pyrimidine nucleotides also stimulate neutrophils, the 
question arises whether pyrimidine nucleotides mediate their 
effects via purinoceptors or via distinct pyrimidinoceptors, 
the existence of which has been suggested in recent studies 
[18, 28, 291. Uracil nucleotides are similarly effective stimu- 
lators of 0; formation, aggregation and degranulation as 
their corresponding adenine analogues (see Tables 1, 4 and 
5). Whereas ATP, GTP and ITP are simiIarly effective acti- 
vators of neutrophils, activation by pyrimidine nucleotides 
exhibits base specificity. UTP is more effective than CTP, and 
TTP is totally inactive. These results indicate that neutrophil 
nucleotide receptors do not only recognize the triphosphate 
but also the base of pyrimidine nucleotides. In addition, there 
is no stereochemical similarity between purine and pyrimidine 
nucleotides. The cross-desensitization between purine and py- 
rimidine nucleotides does not necessarily imply that purine 
and pyrimidine nucleotides act via the same receptor, as cross- 
desensitization between different receptors in neutrophils has 
been reported before [43]. We observed synergistic interaction 
of phosphorothioate analogues of purine and pyrimidine 
nucleotides on 0 2  formation (see Table 2). Synergism be- 
tween signal transduction pathways activated by different 
receptors is a well-known phenomenon in neutrophils (see 
Table 3) [2, 51 and may also be true for purino- and pyrimidi- 
noceptors. Considering the functional similarities between pu- 
rine and pyrimidine nucleotides, it appears likely that pyri- 
midinoceptors represent a class of nucleotide receptors 
functionally related to purinoceptors. Finally, UTP appears 
to be the endogenous ligand for these putative pyrimidino- 
ceptors. 
The nucleotide effects are not specific for the triphos- 
phates. Among the phosphorothioate analogues of nucleoside 
diphosphates, GDP[PS] and UDP[PS] are similarly active as 
the corresponding triphosphates with respect to 0, formation 
and degranulation (see Tables 1 and 4). These findings raise 
the question of whether the receptors can bind tri- as well as 
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Fig. 6. Inhibition of nucleotide- and fMe t -  Leu-PhcJ-induced neutrophil aggregation by pertussis toxin. Neutrophils ( 5  x lo6) were suspended in 
900 p1 assay buffer not supplemented with CaC1,. Cells were incubated for 3 h at 37°C in the presence of pertussis toxin (1 pg/ml) or its 
carrier. Immcdiately following toxin treatment, aggregation assays were performed in the presence of CaCI2 (1  mM). Arrows indicate the 
addition of stimuli to stirred neutrophil suspensions. The extent of aggregation is referred to that induced by met-Leu-Phe (1 pM), which 
effect amounted to 100%. Superimposed original registrations from one experiment performed in quadruplicate are shown. Assay variation 
was less than 10%. Similar results were obtained in six experiments. (A) Control cells. Trace 1, A23187 5 pM; trace 2, UTP or ATP 100 pM; 
trace 3, Met-Leu-Phe 1 pM. (B) Pertussis toxin-treated cells. Trace 1, UTP or ATP 100 pM or Met-Leu-Phe 1 pM; trace 2, A23187 5 pM 
diphosphates. As phosphorothioate analogues of nucleoside 
diphosphates are extremely poor substrates for nucleoside- 
diphosphate kinases and adenylate kinase 115, 381, it is un- 
likely that these nucleotides act as their corresponding 
triphosphates. In addition, the transphosphorylation-resis- 
tant analogue of ATP, [P,y-NHIATP [13], caused a small but 
significant stimulation of 0, formation. Therefore, we con- 
clude that purino- and pyrimidinoceptors recognize tri- as 
well as diphosphates. 
As far as the effects of phosphorothioate analogues on 
0; formation in intact neutrophils are concerned, our results 
suggest that these effects are mediated via purinoceptors and 
not directly via G proteins. First, nucleotides are hydrophilic 
molecules which do not sufficiently cross the plasma mem- 
brane [16, 17, 26, 271. Second, nucleotides do not cause 
permeabilization of neutrophils as revealed by trypan blue 
dye exclusion and release of lactate dehydrogenase. Third, 
GTP[yS] is the most effective activator of G proteins [lo- 
15, 551 but not of neutrophil purinoceptors. Fourth, [P,y- 
NHJGTP is an effective activator of G proteins, whereas it is 
totally inactive at neutrophil purinoceptors. Fifth, GDP[PS] 
competitively antagonizes the effects of GTP[yS] at G proteins 
[7, 10, 14, 151 but additively enhances stimulation of intact 
neutrophils by GTP[yS] and per se is an agonist at neutrophil 
purinoceptors (see Table 2). It is also unlikely that nucleoside- 
diphosphate kinase reactions, leading to the formation of 
GTP[yS] [13], are involved in stimulation of NADPH oxidase 
by extracellular ATP[yS] and UTP[yS] in intact cells. ATP[yS] 
has recently been shown by us to serve as a thiophosphoryl 
group donor for the synthesis of GTP[yS] [13]. This reaction 
is time-dependent, but stimulation of 0; formation by extra- 
cellular nucleotides is rapid in onset without a significant lag 
time (see Fig. 1). In addition, GDP[PS] and UDP[PS] are 
activators of 0, formation in intact cells but no thiophos- 
phoryl group donors in kinase-mediated reactions. Our results 
are in agreement with recent studies demonstrating that 
phosphorothioate analogues of nucleoside diphosphates and 
triphosphates act in the same direction at nucleotide receptors 
[24, 251. 
There are certain functional similarities between 
nucleotides, PAF and LTB4. In analogy to nucleotides, PAF 
and LTB4 bind to specific recpetors and via G proteins activate 
neutrophils [5]. In agreement with previous results we found 
that PAF and LTB4 are less effective activators of 0, forrna- 
tion than met-Leu-Phe [2 ,  31, while nucleotides per se are 
totally inactive (see Table 3). However, cells that have been 
stimulated with a low concentration of the chemotactic 
peptide become responsive to nucleotides. This activation of 
NADPH oxidase by nucleotides is small and short-lasting, 
similarly to activations of 0; formation by PAF and LTB4 
[2]. Nucleotides, PAF and LTB4 synergistically enhance m e t -  
Leu-Phe-induced 0, formation, suggesting that their physio- 
logical function is to potentiate 0; formation induced by 
chemotactic peptides rather than to activate NADPH oxidase 
per se. This interpretation is also supported by the finding 
that combinations of PAF or LTB4 plus nucleotides result 
only in small enhancements of 0; formation. In contrast, the 
combinations of Wet-Leu-Phe plus PAF or LTB4 or 
nucleotides result in very marked synergism. However, the 
combination of PAF plus LTB4 shows more pronounced syn- 
ergistic activation of 0, formation than the combinations of 
lipid mediators with nucleotides. These data indicate that 
PAF and LTB4 on one hand and nucleotides on the other 
hand are functionally related but not equivalent neutrophil 
activators. 
Nucleotides potentiate chemotactic-peptide-induced 0; 
formation and P-glucuronidase release even with both classes 
of stimuli present at high concentrations, indicating that these 
agents induce neutrophil activation via different mechanisms. 
Agonists acting via distinct receptors may additively activate 
G proteins and thus may amplify activation of effector sys- 
tems, i.e. NADPH oxidase and/or phospholipase C, finally 
leading to 0, formation, aggregation and degranulation. In 
addition, occupation of nucleotide receptors with agonists 
may increase the number and/or affinity state of formyl 
peptide receptors as is suggested by the nucleotide-induced 
reduction of the ECSo for NADPH oxidase activation by 
Wet-Leu-Phe. The relatively small synergistic activation of 
0; formation by nucleotides plus lipid mediators in compari- 
son to the combination of nucleotides plus Wet-Leu-Phe may 
be due to the fact that the former combinations lead only a 
small amplification of activation of signal transduction 
components. This interpretation is also supported by the fact 
that PAF and LTB4 lead only to transient activation of 
phospholipase C [49 - 511, as may also be true for nucleotides. 
In summary, we present evidence that nucleotides which 
are released into the extracellular space under various physio- 
logical and pathological conditions may play roles as inter- 
cellular signal molecules in the activation of neutrophils. 
Taking into consideration the fact that extracellular nucleo- 
tides do not only activate neutrophils but also endothelium, 
smooth muscle cells, platelets, mast cells and lymphocytes, 
these agents may act simultaneously and in a coordinated way 
to regulate multiple functions of various cell types, which are 
located close together in vivo. Phosphorothioate analogues of 
purine and pyrimidine nucleotides are useful experimental 
tools to study nucleotide receptors in neutrophils. Finally, 
the development of competitive antagonists for neutrophil 
nucleotide receptors may be an interesting approach to inter- 
fere with inflammatory processes as has already been shown 
for PAF antagonists [55]. 
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